KENNETH LYDA: Open Payments
NPI 1043215999 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 53 payments from 12 companies in 2025. Trend: 2023 $2,839 · 2024 $1,151 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 22 | $297 |
| Abbott Laboratories | 9 | $263 |
| Boston Scientific Corporation | 2 | $139 |
| Amgen Inc. | 4 | $81 |
| ABIOMED | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Edwards Lifesciences Corporation | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| CVRx, Inc. | 1 | $29 |
Products named: LifeVest, AVEIR, Rhythmia Mapping System, REPATHA, Kerendia, ELIQUIS, SAPIEN 3 Ultra RESILIA, LEQVIO.
Industry payments across GA — which companies pay providers there.
